"Antimicrobial resistance, Aboriginal and Torres Strait Islander Health, and Aged Care are among the second set of Medical Research Future Fund (MRFF) priorities for 2018-2020. These priorities will help guide the Morrison Government’s project investments.
The focus areas for research have been set following a thorough national consultation process with over 1,200 community and industry stakeholders.
The priorities take into account the burden of disease experienced by the Australian community and the need to enhance evidence translation in clinical practice.
The 12 new priorities include:
With over $1.7 billion already invested through the MRFF, the Morrison Government’s on-going investments are supercharging the growth in cutting-edge health and medical research. Leading to new cures and treatments that are improving health outcomes across Australia while fuelling jobs, economic growth and export potential.
Our Government’s strong economic management means we can support medical research that gives Australians access to the next generation of life saving technologies.
The $20 billion Medical Research Future Fund was established as an endowment fund to provide a sustainable source of funding for vital medical research and is the single largest boost in health and medical research funding in Australia’s history.
This support is in addition to our record funding for public hospitals, new medicines and Medicare guarantee."
The first set of priorities covered the period 2016-2018. The 2018-2020 priorities now published will determine how funding is awarded over the next two years, and they are organised under the six existing strategic platforms, as follows:
Strategic and International Horizons
- One health – antimicrobial resistance
- Global health and health security
- Aboriginal and Torres Strait Islander Health
- Ageing and aged care
Data and Infrastructure
- Digital health intelligence
Health Services and Systems
- Comparative effectiveness research
- Primary care research
Capacity and Collaboration
- Clinical researcher capacity
- Consumer-driven research
Trials and Translation
- Drug repurposing
- Public health interventions
- Translational research infrastructure